NOV 08, 2019 03:09 PM PST

Does New Chinese Alzheimer's Drug Made from Seaweed Work?

WRITTEN BY: Annie Lennon

It has been almost two decades since the last drug for Alzheimer’s was approved. Now, Chinese reglators have granted conditinal approval for a new drug derived from seaweed that has shown to improve cognitive function in patients with mild to moderate Alzheimer’s. But does it work? 

Unlike other drugs that target getting rid of protein buildup in the brain, this new drug, known as Oligomannate, is said to modulate the connection between the brain and gut bacteria known as the microbiome. According to the researchers behind the drug, “Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate Alzheimer’s patients as early as week 4 and the benefit was sustained at each follow-up assessment visit (Servick: 2019).”

Even though their findings come along a growing body of research that supports a link between neurological disorders and the microbiome, as full data on the drug has not yet been made available, scientists and regulators are hesitant on both the drug’s safety and efficacy. 

Thus, until further research is published, and further trials are conducted, it is difficult to say both how and whether or not the drug works on people. So far, the only evidence that it may work comes from animal studies. 

In September for example, a group of Chinese scientists published a study in which they identified a link between an altered microbiome and neuroinflammation thought to contribute to Alzheimer’s. Treating these mice with Oligomannate, they found that it supressed the bacterial imbalances in the mice’s guts and thus reversed neuroinflammation and cognitive impairment (Wang: 2019). 

Although a promising result, it is worth noting that often what works in mice has little to no effect in humans due to their different brain structures. Regardless of this however, the development of this drug has been met with excitement by some. Maria Carrillo, the Alzheimer’s Association’s chief science officer said that the drug is “is the first step necessary toward a combination approach to treat Alzheimer’s dementia and all dementia.”

For this drug to be available on the US market however, further trials are needed. According to Dr. Jy Snider, a neurologist at ashington University, “We’re always excited to have a new potential treatment...but I certainly would not prescribe it to my patients based on a single study or another country’s approval until we know more about it (Joseph: 2019).”

 

Sources: Science MagNatureStat News 

 

About the Author
  • Writer with a keen interest in genetics, psychology, health and everything in between. Currently focused on the interplay of genetics and society to understand how to create meaningful interactions and environments.
You May Also Like
NOV 21, 2019
Health & Medicine
NOV 21, 2019
On the bright side, optimists may live longer
Do you see the glass half empty, or half full? If your answer is full, you may be in luck: Optimistic people live 11-15% longer than pessimists, according...
NOV 21, 2019
Neuroscience
NOV 21, 2019
Alzheimer's to be Diagnosed from Pupil Dilation
Researchers from the University of California have found a low-cost, non-invasive method to aid in diagnosing Alzheimer’s Disease (AD) before cogniti...
NOV 21, 2019
Neuroscience
NOV 21, 2019
Specialized neurons may hinder memories during dream sleep
Rapid eye movement (REM) sleep is a phase when dreams are created. Traditionally, REM has been thought of as a sleep stage important for memory consolidation, or the long-term storage of memo...
NOV 21, 2019
Neuroscience
NOV 21, 2019
The Most Effective Methods to Improve Your Memory
If there is one thing that everyone would like to improve, it would undoubtedly be memory. This is true for students and professionals alike. After all, yo...
NOV 21, 2019
Genetics & Genomics
NOV 21, 2019
The Risk of Developing PTSD is Influenced by Genetics
It's been estimated that 6 to 9% of Americans experience a trauma that results in post-traumatic stress disorder in their lifetime....
NOV 21, 2019
Neuroscience
NOV 21, 2019
Scientists Create Memory of Courtship Song in Zebra Finches
A new study published in Science shows how a neural circuit in Zebra finches, involved in forming the learning of a courtship song, can be manipulated.&nbs...
Loading Comments...